2-(substituted-phenyl)amino-imidazoline derivatives
1. Field of the Invention This invention relates to IP receptor antagonists selected from the group of compounds represented by Formula I: where:Ris a group represented by formula (A), (B) or (C); and other substituents as defined in the specification, and their pharmaceutically acceptable salts or...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Bley, Keith Roger Clark, Robin Douglas Jahangir, Alam Kowalczyk, Bruce Andrew Lopez-Tapia, Francisco Javier Muehldorf, Alexander Victor O'Yang, Counde Sun, Thomas Weitao |
| description | 1. Field of the Invention
This invention relates to IP receptor antagonists selected from the group of compounds represented by Formula I: where:Ris a group represented by formula (A), (B) or (C); and other substituents as defined in the specification, and their pharmaceutically acceptable salts or crystal forms thereof; and pharmaceutical compositions containing them; and methods for their use as therapeutic agents. |
| format | Patent |
| fullrecord | <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_06472536</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>06472536</sourcerecordid><originalsourceid>FETCH-uspatents_grants_064725363</originalsourceid><addsrcrecordid>eNrjZDA20tUoLk0qLsksKS1JTdEtyEjNq8zRTMzNzMvXzczNTEmsys_JzEtVSEktyixLLMksSy3mYWBNS8wpTuWF0twMCm6uIc4euqXFBYklqXklxfHpRYkgysDMxNzI1NjMmAglAPqCLdM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>2-(substituted-phenyl)amino-imidazoline derivatives</title><source>USPTO Issued Patents</source><creator>Bley, Keith Roger ; Clark, Robin Douglas ; Jahangir, Alam ; Kowalczyk, Bruce Andrew ; Lopez-Tapia, Francisco Javier ; Muehldorf, Alexander Victor ; O'Yang, Counde ; Sun, Thomas Weitao</creator><creatorcontrib>Bley, Keith Roger ; Clark, Robin Douglas ; Jahangir, Alam ; Kowalczyk, Bruce Andrew ; Lopez-Tapia, Francisco Javier ; Muehldorf, Alexander Victor ; O'Yang, Counde ; Sun, Thomas Weitao ; Syntex (U.S.A.) LLC</creatorcontrib><description>1. Field of the Invention
This invention relates to IP receptor antagonists selected from the group of compounds represented by Formula I: where:Ris a group represented by formula (A), (B) or (C); and other substituents as defined in the specification, and their pharmaceutically acceptable salts or crystal forms thereof; and pharmaceutical compositions containing them; and methods for their use as therapeutic agents.</description><language>eng</language><creationdate>2002</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6472536$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,776,798,881,64015</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6472536$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Bley, Keith Roger</creatorcontrib><creatorcontrib>Clark, Robin Douglas</creatorcontrib><creatorcontrib>Jahangir, Alam</creatorcontrib><creatorcontrib>Kowalczyk, Bruce Andrew</creatorcontrib><creatorcontrib>Lopez-Tapia, Francisco Javier</creatorcontrib><creatorcontrib>Muehldorf, Alexander Victor</creatorcontrib><creatorcontrib>O'Yang, Counde</creatorcontrib><creatorcontrib>Sun, Thomas Weitao</creatorcontrib><creatorcontrib>Syntex (U.S.A.) LLC</creatorcontrib><title>2-(substituted-phenyl)amino-imidazoline derivatives</title><description>1. Field of the Invention
This invention relates to IP receptor antagonists selected from the group of compounds represented by Formula I: where:Ris a group represented by formula (A), (B) or (C); and other substituents as defined in the specification, and their pharmaceutically acceptable salts or crystal forms thereof; and pharmaceutical compositions containing them; and methods for their use as therapeutic agents.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2002</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNrjZDA20tUoLk0qLsksKS1JTdEtyEjNq8zRTMzNzMvXzczNTEmsys_JzEtVSEktyixLLMksSy3mYWBNS8wpTuWF0twMCm6uIc4euqXFBYklqXklxfHpRYkgysDMxNzI1NjMmAglAPqCLdM</recordid><startdate>20021029</startdate><enddate>20021029</enddate><creator>Bley, Keith Roger</creator><creator>Clark, Robin Douglas</creator><creator>Jahangir, Alam</creator><creator>Kowalczyk, Bruce Andrew</creator><creator>Lopez-Tapia, Francisco Javier</creator><creator>Muehldorf, Alexander Victor</creator><creator>O'Yang, Counde</creator><creator>Sun, Thomas Weitao</creator><scope>EFH</scope></search><sort><creationdate>20021029</creationdate><title>2-(substituted-phenyl)amino-imidazoline derivatives</title><author>Bley, Keith Roger ; Clark, Robin Douglas ; Jahangir, Alam ; Kowalczyk, Bruce Andrew ; Lopez-Tapia, Francisco Javier ; Muehldorf, Alexander Victor ; O'Yang, Counde ; Sun, Thomas Weitao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_064725363</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2002</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Bley, Keith Roger</creatorcontrib><creatorcontrib>Clark, Robin Douglas</creatorcontrib><creatorcontrib>Jahangir, Alam</creatorcontrib><creatorcontrib>Kowalczyk, Bruce Andrew</creatorcontrib><creatorcontrib>Lopez-Tapia, Francisco Javier</creatorcontrib><creatorcontrib>Muehldorf, Alexander Victor</creatorcontrib><creatorcontrib>O'Yang, Counde</creatorcontrib><creatorcontrib>Sun, Thomas Weitao</creatorcontrib><creatorcontrib>Syntex (U.S.A.) LLC</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Bley, Keith Roger</au><au>Clark, Robin Douglas</au><au>Jahangir, Alam</au><au>Kowalczyk, Bruce Andrew</au><au>Lopez-Tapia, Francisco Javier</au><au>Muehldorf, Alexander Victor</au><au>O'Yang, Counde</au><au>Sun, Thomas Weitao</au><aucorp>Syntex (U.S.A.) LLC</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>2-(substituted-phenyl)amino-imidazoline derivatives</title><date>2002-10-29</date><risdate>2002</risdate><abstract>1. Field of the Invention
This invention relates to IP receptor antagonists selected from the group of compounds represented by Formula I: where:Ris a group represented by formula (A), (B) or (C); and other substituents as defined in the specification, and their pharmaceutically acceptable salts or crystal forms thereof; and pharmaceutical compositions containing them; and methods for their use as therapeutic agents.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_uspatents_grants_06472536 |
| source | USPTO Issued Patents |
| title | 2-(substituted-phenyl)amino-imidazoline derivatives |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T03%3A02%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Bley,%20Keith%20Roger&rft.aucorp=Syntex%20(U.S.A.)%20LLC&rft.date=2002-10-29&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E06472536%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |